News

MINIject presented at MIGS Symposium 2021

MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, will be presented in two lectures at the upcoming MIGS Symposium 2021 on Saturday, 17th April from 11:00AM to 2:30PM CET.

MINIject on best-in-class trajectory at Innovation Summit

CEO Michel Vanbrabant presented to an audience of institutional and strategic investors at the Innovation Summit Dublin on 13-15 April.

STAR-II promising results in Ophthalmology Times

The six and 12-month results from the STAR-II trial on MINIjectTM have been reported in the latest issue of Ophthalmology Times.

iSTAR Medical 2021 roadmap at BioCapital Europe

CEO Michel Vanbrabant will present the company’s latest positive developments and an ambitious 2021 roadmap for iSTAR Medical at the Biocapital Europe meeting on 11 March.

MINIject STAR-II 12-month trial results at AGS

The 12-month results from the European STAR-II trial of iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIjectTM will be presented at the American Glaucoma Society (AGS) meeting.